KATMED
The computed 12-month bankruptcy probability of KATMED is 0.2% (very low). The 2025 annual accounts show equity of €206k and a net result of €16k. Equity is growing by ~23.3% per year across the filed fiscal years. Its solvency ranks better than 71% of 2200 sector peers (fiscal year 2025). The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €206k |
| Net result | €16k |
| Better than sector | 71% |
| Active | 4 yrs |
Strong profile, led by solvency.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 79.8% | 57.9% | |
| Net result | €16k | €60k | |
| Equity | €206k | €74k | |
| Gross operating margin | €86k | €96k | |
| Total assets | €258k | €186k |
| Fiscal year | 2025 |
|---|---|
| Revenue | - |
| EBITDA | €39k |
| Net profit | €16k |
| Cash flow | €24k |
| Staff costs | - |
| Income taxes | €16k |
| Dividends | €833 |
| Total assets | €258k |
| Equity | €206k |
| Debt | €6k |
| of which ≤ 1y | €6k |
| of which > 1y | - |
| Working capital | €230k |
| Employees (FTE) | - |
| 2025 | |
|---|---|
| Current ratio | 42.56 |
| Quick ratio | 42.56 |
| Working capital ratio | 89.0% |
| Solvency | 79.8% |
| Debt / equity | 0.03 |
| Long-term debt ratio | - |
| Interest coverage | 25.41 |
| Gross margin | - |
| Net margin | - |
| ROA | 6.2% |
| ROE | 7.8% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2025 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €258k |
| Fixed assets | 21/28 | €23k |
| Tangible fixed assets | 22/27 | €22k |
| Financial fixed assets | 28 | €300 |
| Current assets | 29/58 | €235k |
| Amounts receivable within one year | 40/41 | €97k |
| Cash & bank | 54/58 | €127k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €258k |
| Equity | 10/15 | €206k |
| Contributions / capital | 10/11 | €4k |
| Accumulated profits (losses) | 14 | €202k |
| Provisions & deferred taxes | 16 | €46k |
| Amounts payable | 17/49 | €6k |
| Amounts payable within one year | 42/48 | €6k |
| Trade debts payable within one year | 44 | €3k |
| Income statement | ||
| Gross operating margin | 9900 | €86k |
| Operating result | 9901 | €31k |
| Financial income | 75 | €3k |
| Financial charges | 65 | €2k |
| Result before taxes | 9903 | €32k |
| Income taxes | 67/77 | €16k |
| Net result for the period | 9904 | €16k |
| Result to be appropriated | 9905 | €16k |
| NACE primary | Human health(86220) |
| Legal form | Private limited company(610) |
| Incorporation | 29-12-2021 |
| Status | Active |
| Postal code | 1780 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 22005A0785/00S004 | Flanders | 1,025 m² | 1 · 92 m² | 11.9 m · 3 fl. |
| 21819D0192/00F003 | Brussels | 318 m² | 1 · 106 m² | 13.3 m · 4 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
19-11-2024 2 directors appointed
- Xavier François C. Rygaert, Bestuurder
- Julien GRAFE, Vaste vertegenwoordiger
Technical details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Xavier Fran\u00E7ois C. Rygaert",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "regular",
"via_org": null,
"statutory": null,
"compensated": false,
"effective_date": "2024-01-01",
"evidence_quote": "De Vergadering neemt kennis van de benoeming van meneer Xavier Fran\u00E7ois C. Rygaert als bestuurder met ingang van 1 januari 2024.",
"decharge_status": null,
"mandate_duration": {
"kind": "indefinite",
"value": null
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
},
{
"kind": "delegation_dagelijks_bestuur_in",
"role": "vaste_vertegenwoordiger",
"person": {
"rrn": null,
"name": "Julien GRAFE",
"address": null,
"birth_date": null,
"profession": "registeraccountant \u0026 Belastingadviseur",
"birth_place": null
},
"reason": null,
"subkind": "regular",
"via_org": {
"kbo": null,
"name": "A. FIDUCIA",
"address": null,
"country": null,
"legal_form": null
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "De vergadering geeft opdracht aan de beloten vennootschap \u0022BCH \u0026 Partners\u0022, vertegenwoordigd door haar administrateur, de vennootschap A. FIDUCIA, vertegenwoordigd door haar vaste vertegenwoordiger, de heer Julien GRAFE, registeraccountant \u0026 Belastingadviseur, met ondernemingsnummer 842.476.177, gev",
"decharge_status": null,
"mandate_duration": {
"kind": "indefinite",
"value": null
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2024-11-19",
"filing_date": "2024-11-07",
"act_kind_objet": "Benoeming van bestuurder / Benoeming en aanwijzing van een gevolmachtigde"
},
"decisions": [],
"is_correction": false,
"subject_company": {
"kbo": "0779.493.483",
"name_full": "KATMED",
"legal_form": "BV"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Julien GRAFE",
"org_rep_person_name": null,
"person_role_at_subject": "Lasthebber"
},
"co_filed_documents": [],
"corrected_publication_numac": null
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | KATMED |